New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas like glioblastoma. Spontaneous astrocytomas in dogs resemble human disease and have been proposed as translational model system for investigation of novel therapeutic strate...
Main Authors: | Waldemar Debinski, Peter Dickinson, John H Rossmeisl, John Robertson, Denise M Gibo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3797726?pdf=render |
Similar Items
-
Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
by: Rossmeisl JH, et al.
Published: (2017-04-01) -
Frame-based stereotactic biopsy of canine brain masses: technique and clinical results in 26 cases
by: John Henry Rossmeisl, et al.
Published: (2015-07-01) -
CANINE BUTTERFLY GLIOBLASTOMAS: A NEURORADIOLOGICAL REVIEW
by: John Henry Rossmeisl, et al.
Published: (2016-05-01) -
IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13
by: Akiva Mintz, et al.
Published: (2002-01-01) -
Receptor-Targeted Glial Brain Tumor Therapies
by: Puja Sharma, et al.
Published: (2018-10-01)